Indian (NIFTY) Biotech Industry Analysis
UpdatedSep 21, 2023
DataAggregated Company Financials
Companies9
- 7D1.2%
- 3M14.0%
- 1Y-5.6%
- YTD3.3%
The Biotech industry is up 2.6% in the last week, with Biocon up 0.9%. In contrast, the industry has lost 8.3% in the last 12 months. Looking forward, earnings are forecast to grow by 40% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Sep 2023 | ₹356.6b | ₹133.8b | ₹4.8b | 29.8x | 74.6x | 2.7x |
| Sat, 19 Aug 2023 | ₹434.8b | ₹142.3b | ₹7.2b | 28.5x | 60.5x | 3.1x |
| Mon, 17 Jul 2023 | ₹340.8b | ₹120.4b | ₹4.5b | 41.8x | 75.6x | 2.8x |
| Wed, 14 Jun 2023 | ₹313.0b | ₹120.3b | ₹4.5b | 41.5x | 69.6x | 2.6x |
| Fri, 12 May 2023 | ₹325.0b | ₹106.7b | ₹16.2b | 28.2x | 20x | 3x |
| Sun, 09 Apr 2023 | ₹287.2b | ₹106.6b | ₹16.4b | 18.3x | 17.6x | 2.7x |
| Tue, 07 Mar 2023 | ₹301.1b | ₹106.5b | ₹16.3b | 32.5x | 18.4x | 2.8x |
| Thu, 02 Feb 2023 | ₹318.7b | ₹99.2b | ₹18.0b | 30.4x | 17.8x | 3.2x |
| Sat, 31 Dec 2022 | ₹347.0b | ₹99.2b | ₹18.0b | 33.5x | 19.3x | 3.5x |
| Mon, 28 Nov 2022 | ₹370.4b | ₹99.2b | ₹18.0b | 34.5x | 20.6x | 3.7x |
| Wed, 26 Oct 2022 | ₹360.2b | ₹95.5b | ₹18.2b | 31.2x | 19.8x | 3.8x |
| Fri, 23 Sep 2022 | ₹381.4b | ₹95.5b | ₹18.1b | 32.4x | 21x | 4x |
| Sun, 21 Aug 2022 | ₹405.1b | ₹95.5b | ₹18.2b | 33.9x | 22.3x | 4.2x |
| Tue, 19 Jul 2022 | ₹433.8b | ₹92.1b | ₹17.7b | 32.1x | 24.6x | 4.7x |
| Thu, 16 Jun 2022 | ₹425.9b | ₹92.1b | ₹17.7b | 31.6x | 24.1x | 4.6x |
| Sat, 14 May 2022 | ₹419.1b | ₹85.4b | ₹6.9b | 51.1x | 60.5x | 4.9x |
| Mon, 11 Apr 2022 | ₹458.6b | ₹79.4b | ₹7.0b | 58.4x | 65.1x | 5.8x |
| Wed, 09 Mar 2022 | ₹424.6b | ₹79.4b | ₹7.0b | 53.7x | 60.3x | 5.4x |
| Fri, 04 Feb 2022 | ₹504.3b | ₹79.4b | ₹7.0b | 66.6x | 71.6x | 6.4x |
| Sun, 02 Jan 2022 | ₹473.0b | ₹76.2b | ₹6.9b | 65.9x | 68.6x | 6.2x |
| Tue, 30 Nov 2021 | ₹467.3b | ₹76.2b | ₹6.9b | 56.2x | 67.8x | 6.1x |
| Thu, 28 Oct 2021 | ₹428.4b | ₹76.1b | ₹6.8b | 50.9x | 63.1x | 5.6x |
| Sat, 25 Sep 2021 | ₹455.6b | ₹75.2b | ₹7.1b | 62.5x | 64.4x | 6.1x |
| Mon, 23 Aug 2021 | ₹420.8b | ₹75.2b | ₹7.1b | 57.8x | 59.5x | 5.6x |
| Sat, 10 Jul 2021 | ₹509.2b | ₹75.2b | ₹7.1b | 70.2x | 72x | 6.8x |
| Fri, 02 Apr 2021 | ₹505.5b | ₹74.3b | ₹7.6b | 56x | 66.6x | 6.8x |
| Mon, 04 Jan 2021 | ₹571.2b | ₹72.0b | ₹6.1b | 92x | 93.5x | 7.9x |
| Thu, 08 Oct 2020 | ₹548.7b | ₹70.7b | ₹6.5b | 50.3x | 84.3x | 7.8x |
Price to Earnings Ratio
84.3x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 74.6x which is higher than its 3-year average PE of 53.5x.
- The 3-year average PS ratio of 5.1x is higher than the industry's current PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 9.8% per year over the last three years.
- Meanwhile revenues for these companies have grown 24% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | 0.0094% | |
| Healthcare | -0.44% | |
| Biotech | 1.21% | |
| Biotech | 1.21% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹273.20 | 0.9% +₹2.8b | -5.6% | PE77.7x | |
| PANACEABIO Panacea Biotec | ₹162.35 | 21.9% +₹1.8b | 11.6% | PE29.8x | |
| 532041 Hindustan Bio Sciences | ₹8.78 | 65.0% +₹35.5m | 143.2% | PS16.9x | |
| 524663 Bharat Immunologicals & Biologicals | ₹24.35 | 2.5% +₹25.5m | -5.3% | PS1.8x | |
| 532039 Zenotech Laboratories | ₹55.77 | 0.7% +₹23.8m | -6.1% | PE29.4x |